Inventor
Edward C. Sherer
Inventor
Manville, NJ, US
Overview
Patents· 10 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations33%
C07DHeterocyclic compounds33%
C07HSugars33%
PatentTitleYear
10,597,422Process for making chloro-substituted nucleoside phosphoramidate compounds202010,214,554Process for making chloro-substituted nucleoside phosphoramidate compounds201910,189,819Factor IXa inhibitors20199,840,478'Piperazine derivatives as HIV protease inhibitors'20179,695,198'Factor IXa inhibitors'20179,006,189'Triazole compounds and methods of making and using the same'20158,841,263'Macrocyclic compounds and methods of making and using the same'20148,742,110'Spiroxazolidinone compounds'20148,278,281'Triazole compounds and methods of making and using the same'20128,202,843'Macrocyclic compounds and methods of making and using the same'2012Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2012–2014Patents assigned to SHERER EDWARD C (4)· patent assignee history
2012–2014Patents assigned to BHATTACHARJEE ASHOKE (3)· patent assignee history
2012–2014Patents assigned to KANYO ZOLTAN F (3)· patent assignee history
2012–2014Patents assigned to CHEN YI (2)· patent assignee history
2012–2019Based in Manville, NJ, US· patent location history
2014–2020Patents assigned to MERCK SHARP & DOHME (6)· patent assignee history
2017–2020Based in Hillsborough, NJ, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| MERCK SHARP & DOHME | 6 | 2014–2020 |
| SHERER EDWARD Cself | 4 | 2012–2014 |
| BHATTACHARJEE ASHOKE | 3 | 2012–2014 |
| KANYO ZOLTAN F | 3 | 2012–2014 |
| CHEN YI | 2 | 2012–2014 |
Locations
| Location | Patents | Span |
|---|---|---|
| Manville, New Jersey, US | 7 | 2012–2019 |
| Hillsborough, New Jersey, US | 3 | 2017–2020 |